Testosterone Replacement Therapy in Wellington, FL: A Physician's Guide for Men Over 40

Andropause (sometimes called late-onset hypogonadism) refers to the constellation of symptoms that appear when a man's testosterone falls below the range his body functions well at. It is not a single number on a lab report. It is the combination of a low serum total and free testosterone with symptoms like persistent fatigue, low libido, erectile changes, loss of morning erections, reduced muscle mass despite training, increased visceral fat, sleep disturbance, brain fog, and low mood.

The Endocrine Society requires both parts of that picture: biochemical confirmation on morning labs drawn on two separate days, and clinical symptoms, before a diagnosis of hypogonadism is made. Treating a lab value alone, or symptoms alone, is not endocrinology.

Appropriate candidates are men with symptomatic, biochemically confirmed low testosterone whose secondary causes have been ruled out. Before we discuss therapy, we look for reversible drivers first: obesity, untreated obstructive sleep apnea, uncontrolled diabetes, chronic opioid use, alcohol excess, and certain medications can all suppress testosterone. Treating those often restores function without exogenous hormones.

TRT is generally not appropriate for men who wish to preserve fertility in the short term (it suppresses sperm production), men with untreated prostate cancer or high-risk prostate findings, poorly controlled heart failure, severe untreated sleep apnea, or hematocrit already at the upper limit. A careful history and baseline evaluation is what distinguishes a physician-led program from a subscription-model clinic.

Every TRT evaluation in Wellington starts with morning labs (before 10 a.m., fasting where possible) on two separate days: total testosterone, free or bioavailable testosterone, SHBG, LH, FSH, estradiol, prolactin, a complete blood count, a comprehensive metabolic panel, lipid panel, fasting glucose and HbA1c, PSA (age-appropriate), and often a thyroid panel and vitamin D. In selected cases we add ferritin, cortisol, or DHEA.

That panel does two things. First, it confirms whether testosterone is truly low and, if so, whether the problem is at the testicle (primary) or the pituitary/hypothalamus (secondary), which changes the conversation entirely. Second, it establishes the baseline we will compare every future draw against.

There is no single 'best' formulation. Weekly or twice-weekly intramuscular or subcutaneous testosterone cypionate remains the most predictable and cost-effective option and gives us the tightest dose control. Daily transdermal gels offer smoother levels but require careful handling around partners and children. Long-acting pellets can be convenient but sacrifice the ability to adjust dose quickly if labs or symptoms drift. For younger men who wish to preserve fertility, we frequently favor clomiphene or hCG-based protocols that raise endogenous testosterone rather than replacing it.

The right choice depends on your baseline labs, symptoms, lifestyle, fertility plans, and how your body responds during the first months of therapy. That decision is made together, in the office, not from a quiz.

Libido, mood, and mental clarity often improve within the first 4–6 weeks. Energy and sleep quality typically follow. Body composition changes (reduced visceral fat, gains in lean mass) appear more gradually over 3–6 months and are meaningfully amplified by resistance training and adequate protein. Erectile function often improves but is multifactorial; vascular, medication, and psychological contributors are addressed in parallel.

We recheck labs at 6–8 weeks, 3 months, and 6 months, then twice yearly once stable. We track testosterone (trough, before the next dose), estradiol, hematocrit, PSA, and lipids, and we adjust dose or frequency based on what the numbers and symptoms show together.

The 2023 TRAVERSE trial, the largest randomized cardiovascular safety study of TRT, found no increased risk of major adverse cardiovascular events in middle-aged and older men with hypogonadism treated to physiologic testosterone levels. It also clarified real, monitorable risks: a modest increase in atrial fibrillation, pulmonary embolism, and acute kidney injury: all reasons monitoring is not optional.

Practical safety at PBCM means tracking hematocrit (and therapeutic phlebotomy if it climbs above ~54%), monitoring PSA and prostate symptoms, watching estradiol so we treat symptoms rather than reflexively suppressing it, and coordinating with your primary care physician and, when relevant, cardiologist or urologist.

Most TRT in the U.S. is delivered by clinics with no endocrinologist on staff. Dose is standardized, monitoring is minimal, and secondary causes are rarely investigated. That model can make a man feel better in the short term while missing pituitary disease, unaddressed sleep apnea, undiagnosed diabetes, or hematologic problems that TRT can unmask.

Dr. Frisch's training in endocrinology means the same rigor applied to thyroid disease, adrenal disorders, and diabetes is applied here: accurate diagnosis first, individualized therapy second, disciplined monitoring throughout. That is the difference between hormone replacement and hormone care.

Testosterone care rarely stands alone. Sleep, resistance training, nutrition, alcohol, and metabolic health influence outcomes more than any single injection. Where appropriate we integrate medical weight management, VitellaMD daily wellness support, aesthetic treatments for skin quality, and PRP for hair concerns, so the plan reflects how you actually want to look, feel, and function in your 40s, 50s, and beyond.